Oruka Therapeutics (ORKA) Cash from Financing Activities (2010 - 2026)
Oruka Therapeutics' quarterly Cash from Financing Activities came in at $40.6 million in Q1 2026, up 13524.16% quarter-over-quarter from $298000.0 in Q4 2025.
Oruka Therapeutics has reported Cash from Financing Activities for 14 years, with the latest figure at $40.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $40.6 million; the trailing twelve-month figure through Mar 2026 stood at $210.3 million (changed N/A YoY), and the FY2025 full-year result was $170.3 million, down 62.11% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $40.6 million, up from $298000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $423.7 million in Q3 2024, with the low at -$1.6 million in Q2 2024.
- Average Cash from Financing Activities over 3 years is $94.3 million, with a median of $27.9 million recorded in 2024.
- Peak annual rise in Cash from Financing Activities reached 156.65% in 2025, while the deepest fall reached 59.9% in 2025.
- Tracing ORKA's Cash from Financing Activities over 3 years: stood at -$526000.0 in 2024, then surged by 156.65% to $298000.0 in 2025, then surged by 13524.16% to $40.6 million in 2026.
- The last three Cash from Financing Activities figures came in at $40.6 million (Q1 2026), $298000.0 (Q4 2025), and $169.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 40.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.60 Mn |
| Mar 31, 2026 | 40.60 Mn |
| Dec 31, 2025 | 298,000.00 |
| Dec 31, 2025 | 298,000.00 |
| Sep 30, 2025 | 169.91 Mn |
| Sep 30, 2025 | 169.91 Mn |
| Dec 31, 2024 | -526,000.00 |
| Dec 31, 2024 | -526,000.00 |
| Sep 30, 2024 | 423.74 Mn |
| Sep 30, 2024 | 423.74 Mn |
| Jun 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -1.59 Mn |
| Mar 31, 2024 | 27.91 Mn |
| Mar 31, 2024 | 27.91 Mn |
| Mar 31, 2021 | 23.09 Mn |
| Mar 31, 2021 | 23.09 Mn |
| Dec 31, 2020 | 984,000.00 |
| Dec 31, 2020 | 984,000.00 |
| Sep 30, 2020 | 42.06 Mn |
| Sep 30, 2020 | 42.06 Mn |
| Dec 31, 2019 | -122,000.00 |
| Dec 31, 2019 | -122,000.00 |
| Sep 30, 2019 | 568,000.00 |
| Sep 30, 2019 | 568,000.00 |
| Jun 30, 2019 | 3.15 Mn |
| Jun 30, 2019 | 3.15 Mn |
| Mar 31, 2019 | 2.96 Mn |
| Mar 31, 2019 | 2.96 Mn |
| Dec 31, 2018 | -105,000.00 |
| Dec 31, 2018 | -105,000.00 |
| Jun 30, 2018 | -207,000.00 |
| Jun 30, 2018 | -207,000.00 |
| Mar 31, 2018 | 3.42 Mn |
| Mar 31, 2018 | 3.42 Mn |
| Dec 31, 2017 | 7,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Sep 30, 2017 | 3.95 Mn |
| Sep 30, 2017 | 3.95 Mn |
| Jun 30, 2017 | 1.79 Mn |
| Jun 30, 2017 | 1.79 Mn |
| Mar 31, 2017 | 105,000.00 |
| Mar 31, 2017 | 105,000.00 |
| Dec 31, 2015 | -58,000.00 |
| Dec 31, 2015 | -58,000.00 |
| Sep 30, 2015 | -200,000.00 |
| Sep 30, 2015 | -200,000.00 |
| Jun 30, 2015 | 34.31 Mn |
| Jun 30, 2015 | 34.31 Mn |
| Mar 31, 2015 | -55,000.00 |
| Mar 31, 2015 | -55,000.00 |
| Dec 31, 2014 | -2,000.00 |
| Dec 31, 2014 | -2,000.00 |
| Sep 30, 2014 | -51,000.00 |
| Sep 30, 2014 | -51,000.00 |
| Jun 30, 2014 | -57,000.00 |
| Jun 30, 2014 | -57,000.00 |
| Mar 31, 2014 | 8.13 Mn |
| Mar 31, 2014 | 8.13 Mn |
| Sep 30, 2013 | -55,000.00 |
| Sep 30, 2013 | -55,000.00 |
| Jun 30, 2013 | 17.82 Mn |
| Jun 30, 2013 | 17.82 Mn |
| Mar 31, 2013 | 1.39 Mn |
| Mar 31, 2013 | 1.39 Mn |
| Dec 31, 2012 | 508,000.00 |
| Dec 31, 2012 | 508,000.00 |
| Sep 30, 2012 | 674,000.00 |
| Sep 30, 2012 | 674,000.00 |
| Jun 30, 2012 | -67,000.00 |
| Jun 30, 2012 | -67,000.00 |
| Mar 31, 2012 | -60,000.00 |
| Mar 31, 2012 | -60,000.00 |
| Dec 31, 2011 | 1.43 Mn |
| Dec 31, 2011 | 1.43 Mn |
| Sep 30, 2011 | -40,000.00 |
| Sep 30, 2011 | -40,000.00 |
| Sep 30, 2010 | 1,000.00 |
| Sep 30, 2010 | 1,000.00 |